Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 107

1.

Human endogenous retrovirus K (HML-2) elements in the plasma of people with lymphoma and breast cancer.

Contreras-Galindo R, Kaplan MH, Leissner P, Verjat T, Ferlenghi I, Bagnoli F, Giusti F, Dosik MH, Hayes DF, Gitlin SD, Markovitz DM.

J Virol. 2008 Oct;82(19):9329-36. doi: 10.1128/JVI.00646-08. Epub 2008 Jul 16.

2.

Characterization of human endogenous retroviral elements in the blood of HIV-1-infected individuals.

Contreras-Galindo R, Kaplan MH, Contreras-Galindo AC, Gonzalez-Hernandez MJ, Ferlenghi I, Giusti F, Lorenzo E, Gitlin SD, Dosik MH, Yamamura Y, Markovitz DM.

J Virol. 2012 Jan;86(1):262-76. doi: 10.1128/JVI.00602-11. Epub 2011 Oct 26.

3.

Human endogenous retrovirus type K antibodies and mRNA as serum biomarkers of early-stage breast cancer.

Wang-Johanning F, Li M, Esteva FJ, Hess KR, Yin B, Rycaj K, Plummer JB, Garza JG, Ambs S, Johanning GL.

Int J Cancer. 2014 Feb 1;134(3):587-95. doi: 10.1002/ijc.28389. Epub 2013 Sep 13.

4.

Detection of HERV-K(HML-2) viral RNA in plasma of HIV type 1-infected individuals.

Contreras-Galindo R, Kaplan MH, Markovitz DM, Lorenzo E, Yamamura Y.

AIDS Res Hum Retroviruses. 2006 Oct;22(10):979-84.

5.

Human endogenous retrovirus family HERV-K(HML-2) RNA transcripts are selectively packaged into retroviral particles produced by the human germ cell tumor line Tera-1 and originate mainly from a provirus on chromosome 22q11.21.

Ruprecht K, Ferreira H, Flockerzi A, Wahl S, Sauter M, Mayer J, Mueller-Lantzsch N.

J Virol. 2008 Oct;82(20):10008-16. doi: 10.1128/JVI.01016-08. Epub 2008 Aug 6.

6.

HIV-1 Infection of Primary CD4+ T Cells Regulates the Expression of Specific Human Endogenous Retrovirus HERV-K (HML-2) Elements.

Young GR, Terry SN, Manganaro L, Cuesta-Dominguez A, Deikus G, Bernal-Rubio D, Campisi L, Fernandez-Sesma A, Sebra R, Simon V, Mulder LCF.

J Virol. 2017 Dec 14;92(1). pii: e01507-17. doi: 10.1128/JVI.01507-17. Print 2018 Jan 1.

PMID:
29046457
7.

Expression of human endogenous retrovirus k envelope transcripts in human breast cancer.

Wang-Johanning F, Frost AR, Johanning GL, Khazaeli MB, LoBuglio AF, Shaw DR, Strong TV.

Clin Cancer Res. 2001 Jun;7(6):1553-60.

8.

Human Endogenous Retrovirus Type K (HERV-K) Particles Package and Transmit HERV-K-Related Sequences.

Contreras-Galindo R, Kaplan MH, Dube D, Gonzalez-Hernandez MJ, Chan S, Meng F, Dai M, Omenn GS, Gitlin SD, Markovitz DM.

J Virol. 2015 Jul;89(14):7187-201. doi: 10.1128/JVI.00544-15. Epub 2015 Apr 29.

9.

Human endogenous retrovirus K (HML-2) RNA and protein expression is a marker for human embryonic and induced pluripotent stem cells.

Fuchs NV, Loewer S, Daley GQ, Izsvák Z, Löwer J, Löwer R.

Retrovirology. 2013 Oct 24;10:115. doi: 10.1186/1742-4690-10-115.

10.

HIV-1 infection leads to increased transcription of human endogenous retrovirus HERV-K (HML-2) proviruses in vivo but not to increased virion production.

Bhardwaj N, Maldarelli F, Mellors J, Coffin JM.

J Virol. 2014 Oct;88(19):11108-20. doi: 10.1128/JVI.01623-14. Epub 2014 Jul 23.

11.

Genomic organization of the human endogenous retrovirus HERV-K(HML-2.HOM) (ERVK6) on chromosome 7.

Reus K, Mayer J, Sauter M, Scherer D, Müller-Lantzsch N, Meese E.

Genomics. 2001 Mar 15;72(3):314-20.

PMID:
11401447
12.

Genomic flexibility of human endogenous retrovirus type K.

Dube D, Contreras-Galindo R, He S, King SR, Gonzalez-Hernandez MJ, Gitlin SD, Kaplan MH, Markovitz DM.

J Virol. 2014 Sep 1;88(17):9673-82. doi: 10.1128/JVI.01147-14. Epub 2014 Jun 11.

13.

The distribution of insertionally polymorphic endogenous retroviruses in breast cancer patients and cancer-free controls.

Wildschutte JH, Ram D, Subramanian R, Stevens VL, Coffin JM.

Retrovirology. 2014 Aug 12;11:62. doi: 10.1186/s12977-014-0062-3.

14.
15.

Identification of the protease cleavage sites in a reconstituted Gag polyprotein of an HERV-K(HML-2) element.

George M, Schwecke T, Beimforde N, Hohn O, Chudak C, Zimmermann A, Kurth R, Naumann D, Bannert N.

Retrovirology. 2011 May 9;8:30. doi: 10.1186/1742-4690-8-30.

16.

Regulation of the human endogenous retrovirus K (HML-2) transcriptome by the HIV-1 Tat protein.

Gonzalez-Hernandez MJ, Cavalcoli JD, Sartor MA, Contreras-Galindo R, Meng F, Dai M, Dube D, Saha AK, Gitlin SD, Omenn GS, Kaplan MH, Markovitz DM.

J Virol. 2014 Aug;88(16):8924-35. doi: 10.1128/JVI.00556-14. Epub 2014 May 28.

17.

Human endogenous retroviruses and cancer prevention: evidence and prospects.

Cegolon L, Salata C, Weiderpass E, Vineis P, Palù G, Mastrangelo G.

BMC Cancer. 2013 Jan 3;13:4. doi: 10.1186/1471-2407-13-4.

18.

A novel multiplex RT-PCR system detects human endogenous retrovirus-K in breast cancer.

Ejthadi HD, Martin JH, Junying J, Roden DA, Lahiri M, Warren P, Murray PG, Nelson PN.

Arch Virol. 2005 Jan;150(1):177-84. Epub 2004 Sep 21.

PMID:
15449135
19.
20.

Reconstitution of an infectious human endogenous retrovirus.

Lee YN, Bieniasz PD.

PLoS Pathog. 2007 Jan;3(1):e10.

Supplemental Content

Support Center